Re: New Pacer--JOINT MOTION AND STIPULATION TO CONTINUE STAY AND HEARING ON MOTION T

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Pacer--JOINT MOTION AND STIPULATION TO CONTINUE STAY AND HEARING ON MOTION T

in response to

Re: New Pacer--JOINT MOTION AND STIPULATION TO CONTINUE STAY AND HEARING ON MOTION T

pacard

posted on Mar 02, 2010 01:14PM

I'm not sure how a FINRA arbitration becomes scheduled if only one party is going to be there. But I guess anything is possible.

< If the market normalizes it undermines their claims.>

Well you do have that IF in there. But DB is going to be stuck with all this ARS paper, if the market does not normalize. Wouldn't normalization also make it easier for DB to settle these claims?

You seem to think that PTSC's agreeing to another stay is meaningless. Well, that just doesn't sound very logical to me. Perhaps beyond me, as you say.